These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37864287)

  • 21. RosettaAntibody: antibody variable region homology modeling server.
    Sircar A; Kim ET; Gray JJ
    Nucleic Acids Res; 2009 Jul; 37(Web Server issue):W474-9. PubMed ID: 19458157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
    Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
    J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computer-aided antibody design.
    Kuroda D; Shirai H; Jacobson MP; Nakamura H
    Protein Eng Des Sel; 2012 Oct; 25(10):507-21. PubMed ID: 22661385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation of Framework Residue H71 Results in Different Antibody Paratope States in Solution.
    Fernández-Quintero ML; Kroell KB; Hofer F; Riccabona JR; Liedl KR
    Front Immunol; 2021; 12():630034. PubMed ID: 33737932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies as a model system for comparative model refinement.
    Sellers BD; Nilmeier JP; Jacobson MP
    Proteins; 2010 Aug; 78(11):2490-505. PubMed ID: 20602354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline-Dependent Antibody Paratope States and Pairing Specific V
    Fernández-Quintero ML; Kroell KB; Bacher LM; Loeffler JR; Quoika PK; Georges G; Bujotzek A; Kettenberger H; Liedl KR
    Front Immunol; 2021; 12():675655. PubMed ID: 34447370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural classification of CDR-H3 in antibodies.
    Shirai H; Kidera A; Nakamura H
    FEBS Lett; 1996 Dec; 399(1-2):1-8. PubMed ID: 8980108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward high-resolution homology modeling of antibody Fv regions and application to antibody-antigen docking.
    Sivasubramanian A; Sircar A; Chaudhury S; Gray JJ
    Proteins; 2009 Feb; 74(2):497-514. PubMed ID: 19062174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
    Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
    J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain.
    Chen W; Zhu Z; Feng Y; Xiao X; Dimitrov DS
    J Mol Biol; 2008 Oct; 382(3):779-89. PubMed ID: 18687338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies.
    Persson H; Ye W; Wernimont A; Adams JJ; Koide A; Koide S; Lam R; Sidhu SS
    J Mol Biol; 2013 Feb; 425(4):803-11. PubMed ID: 23219464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Single-Framework Synthetic Antibody Library Containing a Combination of Canonical and Variable Complementarity-Determining Regions.
    Maruthachalam BV; El-Sayed A; Liu J; Sutherland AR; Hill W; Alam MK; Pastushok L; Fonge H; Barreto K; Geyer CR
    Chembiochem; 2017 Nov; 18(22):2247-2259. PubMed ID: 28884521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving Loop Modeling of the Antibody Complementarity-Determining Region 3 Using Knowledge-Based Restraints.
    Finn JA; Koehler Leman J; Willis JR; Cisneros A; Crowe JE; Meiler J
    PLoS One; 2016; 11(5):e0154811. PubMed ID: 27182833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RosettaCM for antibodies with very long HCDR3s and low template availability.
    Kodali P; Schoeder CT; Schmitz S; Crowe JE; Meiler J
    Proteins; 2021 Nov; 89(11):1458-1472. PubMed ID: 34176159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Superhumanized" antibodies: reduction of immunogenic potential by complementarity-determining region grafting with human germline sequences: application to an anti-CD28.
    Tan P; Mitchell DA; Buss TN; Holmes MA; Anasetti C; Foote J
    J Immunol; 2002 Jul; 169(2):1119-25. PubMed ID: 12097421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling and docking of antibody structures with Rosetta.
    Weitzner BD; Jeliazkov JR; Lyskov S; Marze N; Kuroda D; Frick R; Adolf-Bryfogle J; Biswas N; Dunbrack RL; Gray JJ
    Nat Protoc; 2017 Feb; 12(2):401-416. PubMed ID: 28125104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ab initio structure prediction of the antibody hypervariable H3 loop.
    Zhu K; Day T
    Proteins; 2013 Jun; 81(6):1081-9. PubMed ID: 23255066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design.
    Adolf-Bryfogle J; Kalyuzhniy O; Kubitz M; Weitzner BD; Hu X; Adachi Y; Schief WR; Dunbrack RL
    PLoS Comput Biol; 2018 Apr; 14(4):e1006112. PubMed ID: 29702641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benchmarking GPCR homology model template selection in combination with de novo loop generation.
    Szwabowski GL; Castleman PN; Sears CK; Wink LH; Cole JA; Baker DL; Parrill AL
    J Comput Aided Mol Des; 2020 Oct; 34(10):1027-1044. PubMed ID: 32737667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of VH-VL domain orientation for antibody variable domain modeling.
    Bujotzek A; Dunbar J; Lipsmeier F; Schäfer W; Antes I; Deane CM; Georges G
    Proteins; 2015 Apr; 83(4):681-95. PubMed ID: 25641019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.